BACKGROUND: Vaginal misoprostol has been shown to be an effective single agent for
medical abortion. This randomized, double-blinded, placebo-controlled trial compared a …

BACKGROUND: A combination of mifepristone and misoprostol provides an effective
method of medical abortion for early pregnancy. This is the first randomized trial comparing …

Mifepristone was recently approved in the United States. Regimens with shorter intervals
may be more acceptable. The objective of this study was to determine whether the oral route …

ContextThe conventional timing of misoprostol administration after mifepristone for medical
abortion is 2 days, but more flexible intervals, which may make the regimen more …

In France, mifepristone in association with orally administered misoprostol is widely used for
the early termination of pregnancy (up to 49 days' gestation). In other centers, mifepristone in …

BACKGROUND: A combination of mifepristone and misoprostol provides an effective
method of medical abortion for early pregnancy. A new route of administration of …

This prospective, open-label, randomized trial of healthy adult women up to 9 weeks
pregnant compared mifepristone 200 mg followed 2 days later with misoprostol 400 μg …

BACKGROUND: Several studies have now reported the successful use of the sublingual
administration of misoprostol for medical abortion in the first trimester. The objective of this …

OBJECTIVE: To demonstrate equivalence between mifepristone 200 mg followed 6 to 8
hours later and 24 hours later by misoprostol 800 μg vaginally for abortion in women up to …

Objective To determine the efficacy of oral mifepristone followed by vaginal misoprostol 6
hours later compared with the standard 36‐to 48‐hour regimen for medical termination of …